(Q44473040)

3 December 2017

1 reference

title

Liposomes as drug delivery system: a strategic approach for the treatment of HIV infection (English)

1 reference

3 December 2017

1 reference

Désormeaux A

1

1 reference

3 December 2017

Bergeron MG

series ordinal

2

1 reference

3 December 2017

language of work or name

1 reference

1 January 1998

1 reference

Journal of Drug Targeting

3 December 2017

published in

1 reference

3 December 2017

volume

6

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

1-15

1 reference

Lipid composition and fluidity of the human immunodeficiency virus

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

How do the polyene macrolide antibiotics affect the cellular membrane properties?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Replication of human immunodeficiency virus 1 and Moloney murine leukemia virus is inhibited by different heteroatom-containing analogs of myristic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Recent advances in liposomal drug-delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Targeting of poly(rI)-poly(rC) by fusogenic (F protein) immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Multifactorial nature of human immunodeficiency virus disease: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Liposome targeting to human immunodeficiency virus type 1-infected cells via recombinant soluble CD4 and CD4 immunoadhesin (CD4-IgG).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Lymphoid germinal centers are reservoirs of human immunodeficiency virus type 1 RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Therapeutic efficacy of liposome-encapsulated ribavirin and muramyl tripeptide in experimental infection with influenza or herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

21 January 2018

Overview of liposomes

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Engineering liposomes for drug delivery: progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Follicular dendritic cells and human immunodeficiency virus infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Physical and biological characterization of antigen presenting liposome formulations: relative efficacy for the treatment of recurrent genital HSV-2 in guinea pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Brain drug delivery of small molecules using immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Direct cerebrospinal fluid delivery of an antiretroviral agent using multivesicular liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Animal models for anti-AIDS therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Liposomes modulate human immunodeficiency virus infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Long-term noncytopathic productive infection of the human monocytic leukemia cell line THP-1 by human immunodeficiency virus type 1 (HIV-1IIIB).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Enhancement of human immunodeficiency virus type 1 infection by cationic liposomes: the role of CD4, serum and liposome-cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Fusion of simian immunodeficiency virus with liposomes and erythrocyte ghost membranes: effects of lipid composition, pH and calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Human immunodeficiency virus type 1 (HIV-1) fusion with model membranes: kinetic analysis and the role of lipid composition, pH and divalent cations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

The Lipophilic Muramyl Peptide MTP-PE Is a Potent Inhibitor of HIV Replication in Macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Human immunodeficiency virus (HIV-1) cytotoxicity: perturbation of the cell membrane and depression of phospholipid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Comparison of cellular accumulation, tissue distribution, and anti-HIV activity of free and liposomal 2',3'-dideoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Cordycepin analogues of 2',5'-oligoadenylate inhibit human immunodeficiency virus infection via inhibition of reverse transcriptase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Immunogenicity of immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

A new cationic liposome encapsulating genetic material. A potential delivery system for polynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Pharmacokinetics of liposomal nystatin in patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Human immunodeficiency virus. Trapped but still dangerous

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Interactions of human lymphoblasts with targeted vesicles containing Sendai virus envelope proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Inhibition of HIV-1 replication in H9 cells by nystatin-A compared with other antiviral agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Inhibition of HIV replication by immunoliposomal antisense oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: anti-HIV activity, physical properties, and interaction with plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Enhanced delivery to target cells by heat-sensitive immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Inhibition of HIV-1 in monocyte/macrophage cultures by 2',3'-dideoxycytidine-5'-triphosphate, free and in liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

The past, present, and future uses of liposomes in treating infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Viral dynamics in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Sterically stabilized liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Inhibition of HIV-1 replication in cultured cells with phosphorylated dideoxyuridine derivatives encapsulated in immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Antisense oligonucleotides in solution or encapsulated in immunoliposomes inhibit replication of HIV-1 by several different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Synthesis and anti-HIV activity of thiocholesteryl-coupled phosphodiester antisense oligonucleotides incorporated into immunoliposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611869808997877

10.3109/10611869808997877

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference